KBIO LABS Inc. (KOSDAQ:038530)
South Korea flag South Korea · Delayed Price · Currency is KRW
999.00
+39.00 (4.06%)
At close: Aug 26, 2026

KBIO LABS Revenue

KBIO LABS had revenue of 12.24B KRW in the quarter ending June 30, 2026, with 22.25% growth. This brings the company's revenue in the last twelve months to 92.08B, up 57.61% year-over-year. In the year 2025, KBIO LABS had annual revenue of 87.31B with 14.11% growth.

Revenue (ttm)
92.08B
Revenue Growth
+57.61%
P/S Ratio
0.28
Revenue / Employee
2.42B
Employees
38
Market Cap
25.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202587.31B10.80B14.11%
Dec 31, 202476.51B49.19B180.02%
Dec 31, 202327.32B-3.80B-12.22%
Dec 31, 202231.13B22.41B256.90%
Dec 31, 20218.72B3.01B52.80%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CammSys500.33B
Photon139.52B
Signetics111.50B
CNPLUS73.82B
PIMS Inc.58.18B
Seoul Electronics & Telecom30.49B
NWC Co.,Ltd.26.25B
SD SYSTEM20.66B
Revenue Rankings